{
  "url": "https://openlegislation.uk/eu-directive-2004-33/annex-I/division-6",
  "json_url": "https://openlegislation.uk/eu-directive-2004-33/annex-I/division-6.json",
  "legislation": "eudr/2004/33",
  "legislation_title": "Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-directive-2004-33",
  "path": "annex/I/division/6",
  "kind": "division",
  "number": "6",
  "heading": null,
  "text": "‘Plasma’ means the liquid portion of the blood in which the cells are suspended. Plasma may be separated from the cellular portion of a whole blood collection for therapeutic use as fresh-frozen plasma or further processed to cryoprecipitate and cryoprecipitate-depleted plasma for transfusion. It may be used for the manufacture of medicinal products derived from human blood and human plasma or used in the preparation of pooled platelets, or pooled, leucocyte-depleted platelets. It may also be used for re-suspension of red cell preparations for exchange transfusion or perinatal transfusion.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudr/2004/33/annex/I/division/6",
    "retrieved_at": "2026-11-01T15:22:49.438638+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}